SUICIDALITY in the perinatal period: comparison of two self-report instruments. Results from PND-ReScU
- 301 Downloads
The aim of this study was to assess suicidality in a non-clinical sample during the perinatal period and to report suicidality rates in women with major or minor depressive episode (MmD), assessed with the SCID, during the perinatal period. Women (1,066) were recruited at the third month of pregnancy and followed until the 12th month postpartum (N = 500). Suicidality was assessed with the MOODS-SR and with item 10 of the EPDS at different time-points during the perinatal period. The period prevalence of suicidality was 6.9% (95% CI: 6.0–7.8) during pregnancy and 4.3% (95% CI: 3.4–5.2) during postpartum, assessed with the MOODS-SR, and was 12.0% (95% CI: 10.8–13.2) during pregnancy and 8.6% (95% CI: 7.4–9.8) during the postpartum period, assessed with the EPDS. The prevalence of suicidality in women who had MmD during pregnancy was 26.4% and 34.1%, assessed with the MOODS-SR and the EPDS, respectively, while it was 18.4% (MOODS-SR) and 30.6% (EPDS) during the postpartum period. Clinicians should assess suicidality in women presenting with MmD during the whole perinatal period. Furthermore, suicidality should be assessed in women with a previous history of psychiatric disorder that reported a lifetime suicidal ideation.
KeywordsSuicidality Perinatal period Perinatal depression Risk factors
The PND-ReScU staff includes Cristina Rambelli, MD, Daniele Ramacciotti, MD, Maria Sole Montagnani, MD, Sonia Cortopassi, MD, Valeria Camilleri, MD, Amparo Bettini, D.Psych., Serena Ricciardulli, D.Psych., Serena Luisi, D.Psych., and Caterina Cirri, D.Psych. This research was funded with a grant from the Italian Ministry of Health and with liberal grants from the “Istituto per la ricerca e la prevenzione della Depressione E dell'Ansia” (IDEA), the Stella Major Foundations (no-profit advocacy associations), and Pfizer Italia. The authors would like to thank all the women who participated, without whom this study would not have been possible.
- American Psychiatric Association (APA) (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DCGoogle Scholar
- Banti S, Mauri M, Oppo A et al (2011) From the 3rd month of pregnancy to 1 year postpartum. Prevalence, incidence, recurrence and new onset of depression. Results from the perinatal depression-research & screening unit study. Compr Psychiatry 52(4):343–351 Google Scholar
- Borges G, Nock MK, Haro Abad JM (2010) Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. J Clin Psychiatry. (in press)Google Scholar
- First MB, Spitzer RL, Gibbon M et al (1995) Structured Clinical Interview for DSM-IV Axis I Disorders. New York State Psychiatric Institute, Biometrics Research, New YorkGoogle Scholar
- Food and Drug Administration (1979) Labeling and prescription drug advertising: content and format for labeling for human prescription drugs. Fed Regist 44:37434–37467Google Scholar
- Gaynes BN, Gavin N, Meltzer-Brody S et al (2005) Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 119:1–8Google Scholar
- Horowitz JA, Murphy CA, Gregory KE, Wojcik J (2010) A community-based screening initiative to identify mothers at risk for postpartum depression. J Obstet Gynecol Neonatal Nurs. (in press)Google Scholar
- Lewis G (2004) Confidential enquiry into maternal and child health. Why mothers die 2000–2002. Sixth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. Ch. 11A: Deaths from suicide and other psychiatric causes. RCOG Press, LondonGoogle Scholar